A rare opportunity to acquire a fully integrated telemedicine, remote-patient-monitoring, and augmented-reality clinical collaboration platform built to transform access to care for underserved populations. The company combines proprietary software, purpose-built hardware, and AI-assisted workflows into a single, seamless ecosystem already deployed across Canada and 35 countries of geographic reach.
Designed to solve one of healthcare’s most persistent challenges, the platform enables specialist-level care for rural, remote, and Indigenous communities that often face hours of travel for services readily available in urban centres. Current applications include AR-guided wound care, virtual primary care, community paramedicine, remote surgical mentorship, and real-time medical education delivered through smart-glasses and IoT-enabled TelePresence, Virtual Ward RPN monitoring devices.
The system is hardware-agnostic, cloud/private-cloud/on-premise ready, and engineered for effortless integration into larger health-system infrastructures. Customers include hospitals, government-supported programs, and international health networks.
Motivation: The owner is advancing to a new innovation venture but remains committed to supporting a multi-year transition with a qualified strategic buyer under a flexible, value-aligned deal structure aiming to accelerate platform commercialization. Deal is open to Private equity firms with AI / Technology acquisition focus. Owner will welcome the best offer possible for this unique business.
June 2026 Performance Highlights:
Year-to-date revenue: CAD$600,000+
Annual recurring revenue: ~$400,000 CAD
Recurring revenue: 65%
Renewal rate: 90%+
Software gross margins: 70%+
Additional $1–2M CAD pipeline identified
Sale includes all proprietary IP, deployed hardware, active contracts, and the global commercial pipeline US$1-2M. Founder and key technical staff are available for a structured transition period. Full financials, architecture, and customer details available upon NDA.
